Patents Examined by D. B. Springer
  • Patent number: 4755518
    Abstract: Novel benzoic acid or benzoic acid ester derivatives, pharmaceutical compositions and methods of use thereof are the present invention. Utility is for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel disorders, trigeminal or herpetic neuralgia, inflammatory eye disorders, psoriasis, dental pain, and headaches, particularly vascular headaches, such as migraine, cluster, mixed vascular syndromes, as well as nonvascular, tension headaches.
    Type: Grant
    Filed: November 10, 1986
    Date of Patent: July 5, 1988
    Assignee: Warner-Lambert Company
    Inventors: Michael F. Rafferty, Graham Johnson
  • Patent number: 4751232
    Abstract: A novel pyrrolizidine derivative of the formula, ##STR1## which has potent antiarrhythmic activity and low toxicity is produced. The derivative can be synthesized: by acylating 2,6-xylidine to protect the amino group, nitrating the protected xylidine to introduce a nitro group at 3-position, reducing the nitro group to an amino group, followed by diazotizing and hydrolyzing, and then the resulted 3-hydroxy-2,6-dimethylaniline being condensed with 8-halocarbonylmethylpyrrolizidine; or by nitrating N-(2',6'-dimethyl)phenyl-8-pyrrolizidineacetamide to introduce a nitro group at 3'-position, reducing the nitro group to amino group, diazotizing the amino group and hydrolyzing the diazonium compound.
    Type: Grant
    Filed: February 21, 1985
    Date of Patent: June 14, 1988
    Assignee: Suntory Limited
    Inventors: Fumio Satoh, Keiyu Shima, Takafumi Ishihara
  • Patent number: 4751222
    Abstract: Novel 2,3,4,5-tetrahydro-1H-3-benzazepines which in the 5-position have furyl, thienyl, pyridyl, or ring systems consisting of phenyl ortho condensed with a benzen, cyclohexan, cyclohexen, cyclopentan or cyclopenten ring wherein one of the carbon atoms may be exchanged with oxygen, sulphur or nitrogen, have interesting central nervous system and cardiovascular effects.
    Type: Grant
    Filed: April 21, 1986
    Date of Patent: June 14, 1988
    Assignee: Novo Industri A/S
    Inventors: Claus Braestrup, Peter H. Andersen, Poul Borrevang, Frederik C. Gr nvald, Louis B. Hansen, Rolf Hohlweg
  • Patent number: 4751233
    Abstract: Novel 8-thiotetrahydroquinolines of the formula ##STR1## wherein X is selected from the group consisting of ##STR2## Alk is alkyl of 1 to 6 carbon atoms, R.sub.1 and R.sub.2 are Alk individually selected from the group consisting of hydrogen and aryl or taken together with the carbon atoms to which they are attached form a phenyl optionally substituted with at least one member of the group consisting of alkyl, alkoxy and alkylthio of 1 to 6 carbon atoms, halogen, ##STR3## and Alk' is alkyl of 1 to 6 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having antiallergic activity and their preparation.
    Type: Grant
    Filed: February 26, 1986
    Date of Patent: June 14, 1988
    Assignee: Roussel Uclaf
    Inventors: Stephen Clements-Jewery, Peter D. Kennewell, Robert Westwood
  • Patent number: 4749406
    Abstract: There are used for the protection of cultivated plants against the harmful effects of agricultural chemicals quinoline derivatives of the formula ##STR1## wherein R.sub.1, R.sub.2 and R.sub.3 independently of one another are each hydrogen, halogen, nitro, cyano, alkyl, alkoxy or acyl,R.sub.4, R.sub.5 and R.sub.
    Type: Grant
    Filed: October 12, 1984
    Date of Patent: June 7, 1988
    Assignee: Ciba-Geigy Corporation
    Inventor: Henry Martin
  • Patent number: 4748183
    Abstract: The present invention is for compounds having the formula of N-1H-tetrazol-5-yl-2-thiophenecarboxamides, N-1H-tetrazol-5-yl-2-pyrrolecarboxamides, N-1H-tetrazol-5-yl-2-furancarboxamides or analogs of each of the carboxamides. The compounds are useful for the treatment of allergic or inflammatory conditions or diseases. Thus, pharmaceutical compositions and methods of use are also the invention. Processes of preparation for the compounds are also the invention.
    Type: Grant
    Filed: March 18, 1987
    Date of Patent: May 31, 1988
    Assignee: Warner-Lambert Company
    Inventors: Wiaczeslaw A. Cetenko, David T. Connor, Michael D. Mullican, Roderick J. Sorenson
  • Patent number: 4746743
    Abstract: Process for producing 2,2,4-trimethyl-1,2-dihydroquinoline by reacting aniline with an acetone compound at 80.degree.-150.degree. C. in the presence of, as catalyst, both hydrogen fluoride and boron trifluoride.
    Type: Grant
    Filed: June 21, 1985
    Date of Patent: May 24, 1988
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Masakatsu Yoshimura, Takeo Fujii, Kikumitsu Inoue, Masahito Umehara, Hideo Nagasaki
  • Patent number: 4743686
    Abstract: A new catalytic process for the isomerization of asocainol isomers at the 6-position which provides an inexpensive, rapid, and simple method for large scale production of the (R,R) isomer of (R,S) asocainol is asocainol. The (R,R) isomer of (R,S) asocainol is treated with small amounts of a salt and an oxidizing agent at an elevated temperature. The compounds and their pharmaceutically acceptable salts are useful as potent antiarrhythmic agents and local anesthetics.
    Type: Grant
    Filed: November 17, 1986
    Date of Patent: May 10, 1988
    Assignee: Godecke Akt.
    Inventors: Wolfram Geibel, Wolfgang Herrmann
  • Patent number: 4740506
    Abstract: There are described the novel compound bis-(trimethaphan)-nitroprusside of formula ##STR1## and solvates, especially hydrates or alcoholates thereof, as well as a process for the manufacture thereof from an alkali nitroprusside and a soluble trimethaphan salt, especially sodium nitroprusside and trimethaphan camsylate, in solution, especially in water.Furthermore, there are described pharmaceutical compositions which contain the novel active substance (I) in solid form, in form of concentrated solutions or in form of diluted solutions suitable for infusion purposes.In particular there are described compositions which contain (I) in concentrated solution in at least 40% ethanol or in solid form as well as compositions which contain, in addition to (I), a soluble, physiologically acceptable thiosulphate, in particular sodium thiosulphate.
    Type: Grant
    Filed: January 6, 1983
    Date of Patent: April 26, 1988
    Inventor: Henning Cierpka
  • Patent number: 4740514
    Abstract: There are described compounds of the formula ##STR1## in which R.sup.1 is hydrogen or C.sub.1-6 alkyl, R.sup.2 is hydrogen, C.sub.1-6 alkyl or C.sub.3-6 alkenyl, X and Y are each oxygen, sulphur, sulphinyl or sulphonyl, n is 2 to 6 and Z is 1H-tetrazol-5-yl, 1H-tetrazol-5-ylthio, 1H-tetrazol-5-ylsulphinyl, 1H-tetrazol-5-ylsulphonyl, cyano or thiocyano, provided that when both X and Y are oxygen Z is 1H-tetrazol-5-ylthio, 1H-tetrazol-5-ylsulphinyl, 1H-tetrazol-5-ylsulphonyl or thiocyano; and salts thereof. The compounds in which Z is other than cyano or thiocyano have pharmaceutical activity and inhibit leukotriene action or formation.
    Type: Grant
    Filed: May 27, 1986
    Date of Patent: April 26, 1988
    Assignee: Lilly Industries Limited
    Inventors: John Goldsworthy, Winston S. Marshall, John P. Verge
  • Patent number: 4735948
    Abstract: (1H-Tetrazol-5-yl)-2(1H)-quinolones useful as antiallergic agents are described herein. The compounds are prepared by the reaction of sodium azide and ammonium chloride with an appropriate 3-cyano-2(1H)-quinolinone.
    Type: Grant
    Filed: March 25, 1983
    Date of Patent: April 5, 1988
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventor: Terry L. Wright
  • Patent number: 4731451
    Abstract: The disclosure herein pertains to 2-haloacetamides characterized by substitution on the nitrogen atom of certain heterocyclymethyl radicals and by substituted or unsubstituted cycloalkenyl or phenyl radicals and to a process for the preparation thereof. These compounds are useful as herbicides.
    Type: Grant
    Filed: March 25, 1980
    Date of Patent: March 15, 1988
    Assignee: Monsanto Company
    Inventor: John P. Chupp
  • Patent number: 4731375
    Abstract: A chromene derivative having the general formula (I): ##STR1## wherein n is 1 to 5 and --O--CH.sub.2).sub.n CO.sub.2 H group is attached to 5-position, 6-position, 7-position or 8-position, or salts thereof, a process for preparing the same and antiallergic agents containing the same.The compounds of the present invention inhibit the immunological release of chemical mediators such as SRS-A and histamine from mast cell and have an excellent effect in preventing and treating the various allergic diseases such as allergic asthma, allergic dermatitis, allergic nasitis, hives, allergic enteritis and allergic conjunctivitis, especially allergic asthma.
    Type: Grant
    Filed: December 9, 1985
    Date of Patent: March 15, 1988
    Assignee: Kaken Pharmaceutical Co., Ltd.
    Inventors: Jun Nakano, Toshikazu Awaji, Kiyoshi Kuriyama, Yoshiyuki Hiyama, Toshiaki Okuda
  • Patent number: 4717416
    Abstract: 3,7-Dichloroquinoline derivatives which are substituted in the 8-position by --CH.dbd.CHR or --CH.dbd.NR.sup.5, and their use for controlling undesirable plant growth.
    Type: Grant
    Filed: August 3, 1983
    Date of Patent: January 5, 1988
    Assignee: BASF Aktiengesellschaft
    Inventors: Helmut Hagen, Rolf-Dieter Kohler, Juergen Markert, Bruno Wuerzer
  • Patent number: 4716155
    Abstract: Phosphorus containing compounds of the formula ##STR1## wherein X is a substituted or unsubstituted imino or amino acid and A is ##STR2## These compounds possess angiotensin converting enzyme activity and are thus useful as hypertensive agents.
    Type: Grant
    Filed: January 25, 1985
    Date of Patent: December 29, 1987
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Donald S. Karanewsky, Edward W. Petrillo, Jr.
  • Patent number: 4715889
    Abstract: Quinoline derivatives of the formula ##STR1## where X, n, R.sup.1, R.sup.2 and Y have the meanings given in the description, are used for controlling undesirable plant growth.
    Type: Grant
    Filed: September 7, 1983
    Date of Patent: December 29, 1987
    Assignee: BASF Aktiengesellschaft
    Inventors: Helmut Hagen, Rolf-Dieter Kohler, Jurgen Markert, Bruno Wuerzer
  • Patent number: 4714709
    Abstract: N-(2,10-dioxa-tricyclo-[5,3,1,0.sup.3,8 ]-undecane-5-yl)-tryptamine compounds corresponding to the formula ##STR1## with blood-pressure lowering effects, a method of producing such compounds and pharmaceutical compositions incorporating such compounds, wherein R.sub.1 is hydrogen, a benzyl or lower alkyl group; R.sub.2 is a lower alkyl or lower alkanoyl group; R.sub.3 is hydrogen or a lower alkyl group; R.sub.4 is hydrogen, benzyloxy, hydroxy or a lower alkoxy group; R.sub.5 is hydrogen, benzyloxy, hydroxy or a lower alkoxy group; and A and B either are both hydrogen or together represent a bond between their respective carbons.
    Type: Grant
    Filed: September 24, 1984
    Date of Patent: December 22, 1987
    Assignee: Kali-Chemie Pharma GmbH
    Inventors: Peter W. Thies, Samuel David, Ulrich Kuehl, Gerd Buschmann, Peter Flecker
  • Patent number: 4714708
    Abstract: The invention relates to derivatives of cis,endo-2-azabicyclo[5.3.0]decane-3-carboxylic acid of the formula I ##STR1## in which R denotes hydrogen, alkyl, alkenyl or aralkyl, R.sup.1 denotes hydrogen, allyl, vinyl or a side chain of an optionally protected naturally occurring .alpha.-aminoacid, R.sup.2 denotes hydrogen, alkyl, alkenyl or aralkyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen, or Y and Z together denote oxygen, X denotes alkyl, alkenyl, cycloalkyl, aryl which can be substituted once, twice or three times by alkyl, alkoxy, hydroxyl, halogen, nitro, amino, alkylamino, dialkylamino or methylenedioxy, or denotes indol-3-yl, and their physiologically acceptable salts, a process for their preparation, agents containing them and their use.
    Type: Grant
    Filed: December 14, 1983
    Date of Patent: December 22, 1987
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Hansjorg Urbach, Rainer Henning, Volker Teetz, Reinhard Becker
  • Patent number: 4709036
    Abstract: The present invention provides a process for the preparation of herbicidal 2-(4,4-disubstituted-5-oxo-2-imidazolin-2-yl) benzoic, nicotinic and quinoline-3-carboxylic acids, esters and salts.
    Type: Grant
    Filed: June 13, 1985
    Date of Patent: November 24, 1987
    Assignee: American Cyanamid Company
    Inventors: Marinus Los, Don W. Long, Gregory P. Withers
  • Patent number: 4709052
    Abstract: A soil disease controlling agent for preventing and controlling diseases caused by pathogenic fungi living in soil, which comprises an effective amount of at least one of a 2-cycloalkenylamine derivative and its salts as an active ingredient, and at least one inert carrier or diluent.
    Type: Grant
    Filed: May 16, 1984
    Date of Patent: November 24, 1987
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Hiroki Tomioka, Tadashi Ooishi, Junya Takahashi, Mitsuru Sasaki, Naonori Hirata